Psychedelics Weekly – Drug Testing and Harm Reduction, Ketamine vs. ECT, and Does Therapy Really Work?

June 2, 2023
Featuring: Joe Moore & Kyle Buller

Subscribe Share

In this episode of Psychedelics Weekly, Joe and Kyle are once again able to take advantage of Kyle’s temporary Colorado residency and record together in Joe’s office.

While last week focused on the numerous challenges facing a rapidly growing industry of psychedelic therapists, facilitators, and guides, the topic of therapy itself is put under the microscope this week, as they dissect a New York Times article titled, “Does Therapy Really Work? Let’s Unpack That.” They discuss whether or not therapy is right for everyone, the efficacy of different types of therapy, the role of the therapeutic alliance in treatment outcomes, and how (if it’s even possible) to measure all of these factors.

They also discuss:

-a study showing that ketamine was more effective than ECT (electroconvulsive therapy) for patients with treatment-resistant depression;

-the potential benefits of the LSD analog, Br-LSD, in treating people with major depressive disorders, cluster headaches, and more;

-Ireland’s Health Service Executive launching the Safer Nightlife program, which will partner with music festivals this summer to establish on-site drug testing;

-the U.S. slowly beginning to legalize fentanyl test strips, which, for some reason, are illegal in many parts of the country;

and much more!

See you next week, and if you’re in the NYC area, make sure to check out “Tales of Transformation,” an in-person event Thursday, June 8 at the Athenæum, moderated by David, and featuring Ifetayo Harvey, Juliana Mulligan, and Raad Seraj.


(bolded links are the discussed articles)

Navigating Psychedelics For Clinicians and Wellness Practitioners (the next edition begins July 12 and 13) (use code PT15 for 15% off tickets)

Joe’s IG live with Global Psychedelic Society

California Psychedelic Conference: June 3-4 in Los Angeles Does Therapy Really Work? Let’s Unpack That. The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses Effect of a Layperson-Delivered Telephone Program for People With Depressive Symptoms

The Cato Institute: Jeffrey A. Singer New York City’s Psychedelic Athenæum: A Place To Find The Others

Psychedelics Today – Tales of Transformation: Thursday, June 8, at the Athenæum, 7:00 – 9:30pm EST Ketamine Might Be on Par With the Gold Standard for Treatment-Resistant Depression, Study Finds A Beneficial Psychedelic That Does Not Cause Hallucinations

Psychedelics Today: PT369 – Chronic Pain and Phantom Limb Pain: Could Psilocybin Be the Answer?, featuring: Timothy Furnish, MD & Joel Castellanos, MD

Psychedelics Today: PT245 – Robin Carhart-Harris – Psychedelics, Entropy, and Plasticity How Neurons That Wire Together Fire Together

Psychedelics Today: PT409 – Pathology, The DSM, and The Ontological Shock of Psychedelic Experiences, featuring: Erica Rex & Mona Sobhani, Ph.D. Drug testing to be rolled out at music festivals in Ireland this summer Fentanyl Testing Strips Are Illegal in Many States — but That’s Changing How Conservatives Are Changing Their Mind on Legalizing Fentanyl Test Strips

Alchemically Stoned: The Psychedelic Secret of Freemasonry, by P. D. Newman

Joe Moore 2023

In this Episode

Joe Moore

CEO & Co-Founder

Kyle Buller 2023

Kyle Buller

Vice President of Education + Training & Co-Founder